Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-077042
Filing Date
2012-11-13
Accepted
2012-11-13 08:48:31
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-22389_110q.htm 10-Q 582282
2 EX-31.1 a12-22389_1ex31d1.htm EX-31.1 11774
3 EX-31.2 a12-22389_1ex31d2.htm EX-31.2 11723
4 EX-32.1 a12-22389_1ex32d1.htm EX-32.1 7561
  Complete submission text file 0001104659-12-077042.txt   5489566

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT conx-20120930.xml EX-101.INS 425387
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT conx-20120930.xsd EX-101.SCH 69220
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT conx-20120930_cal.xml EX-101.CAL 56827
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT conx-20120930_def.xml EX-101.DEF 385215
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT conx-20120930_lab.xml EX-101.LAB 1250243
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT conx-20120930_pre.xml EX-101.PRE 553629
Mailing Address 11575 MAIN STREET BROOMFIELD CO 80020
Business Address 11575 MAIN STREET BROOMFIELD CO 80020 303-457-4345
CORGENIX MEDICAL CORP/CO (Filer) CIK: 0001063665 (see all company filings)

EIN.: 931223466 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-24541 | Film No.: 121195946
SIC: 2835 In Vitro & In Vivo Diagnostic Substances